ZA201002095B - Solid dispersion product of n-aryl urea-based drugs - Google Patents

Solid dispersion product of n-aryl urea-based drugs

Info

Publication number
ZA201002095B
ZA201002095B ZA2010/02095A ZA201002095A ZA201002095B ZA 201002095 B ZA201002095 B ZA 201002095B ZA 2010/02095 A ZA2010/02095 A ZA 2010/02095A ZA 201002095 A ZA201002095 A ZA 201002095A ZA 201002095 B ZA201002095 B ZA 201002095B
Authority
ZA
South Africa
Prior art keywords
solid dispersion
based drugs
dispersion product
aryl urea
urea
Prior art date
Application number
ZA2010/02095A
Other languages
English (en)
Inventor
Rudolf Schroeder
Tanja Heitermann
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg
Publication of ZA201002095B publication Critical patent/ZA201002095B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA2010/02095A 2007-10-19 2010-03-24 Solid dispersion product of n-aryl urea-based drugs ZA201002095B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99961807P 2007-10-19 2007-10-19
PCT/EP2008/064076 WO2009050291A2 (fr) 2007-10-19 2008-10-17 Produit de dispersion solide de médicaments de type n-aryle à base d'urée

Publications (1)

Publication Number Publication Date
ZA201002095B true ZA201002095B (en) 2011-11-30

Family

ID=40089463

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2010/02095A ZA201002095B (en) 2007-10-19 2010-03-24 Solid dispersion product of n-aryl urea-based drugs

Country Status (18)

Country Link
EP (1) EP2197425A2 (fr)
JP (1) JP2011500649A (fr)
KR (1) KR20100087170A (fr)
CN (1) CN101827584A (fr)
AU (1) AU2008313622A1 (fr)
BR (1) BRPI0818340A2 (fr)
CA (1) CA2699301A1 (fr)
CO (1) CO6270206A2 (fr)
CR (1) CR11442A (fr)
DO (1) DOP2010000117A (fr)
EC (1) ECSP10010183A (fr)
GT (1) GT201000102A (fr)
MX (1) MX2010004291A (fr)
PA (1) PA8800101A1 (fr)
RU (1) RU2010119929A (fr)
UA (1) UA100865C2 (fr)
WO (1) WO2009050291A2 (fr)
ZA (1) ZA201002095B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090203709A1 (en) * 2008-02-07 2009-08-13 Abbott Laboratories Pharmaceutical Dosage Form For Oral Administration Of Tyrosine Kinase Inhibitor
JO3002B1 (ar) 2009-08-28 2016-09-05 Irm Llc مركبات و تركيبات كمثبطات كيناز بروتين
AU2011264993B2 (en) * 2010-06-09 2014-02-06 Abbvie Bahamas Ltd. Solid dispersions containing kinase inhibitors
CA2855243C (fr) 2011-11-11 2020-04-14 Novartis Ag Procede de traitement d'une maladie proliferative
PL2782557T3 (pl) * 2011-11-23 2019-03-29 Array Biopharma, Inc. Formulacje farmaceutyczne
WO2014003677A1 (fr) * 2012-06-28 2014-01-03 Xspray Microparticles Ab Compositions pharmaceutiques comprenant des particules de dispersion solide contenant du tadalafil
WO2014003678A1 (fr) * 2012-06-28 2014-01-03 Xspray Microparticles Ab Compositions pharmaceutiques comprenant de l'ambrisentan et des particules de dispersion solide contenant du tadalafil

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007050574A1 (fr) * 2005-10-25 2007-05-03 Abbott Laboratories Preparation comprenant un medicament faiblement soluble dans l'eau et son procede d'utilisation
WO2007066189A2 (fr) * 2005-12-09 2007-06-14 Pfizer Products Inc. Sels, promedicaments et formulations de 1-[5-(4-amino-7-isopropyl-7h-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2-methoxy-phenyl]-3-(2,4-dichloro-phenyl)-uree
JP2010509289A (ja) * 2006-11-09 2010-03-25 アボット ゲーエムベーハー ウント コンパニー カーゲー チロシンキナーゼ阻害剤の経口投与用薬学的剤形

Also Published As

Publication number Publication date
CN101827584A (zh) 2010-09-08
CA2699301A1 (fr) 2009-04-23
EP2197425A2 (fr) 2010-06-23
DOP2010000117A (es) 2010-05-15
CR11442A (es) 2010-09-06
WO2009050291A2 (fr) 2009-04-23
CO6270206A2 (es) 2011-04-20
GT201000102A (es) 2012-03-12
BRPI0818340A2 (pt) 2015-04-22
PA8800101A1 (es) 2009-05-15
UA100865C2 (ru) 2013-02-11
RU2010119929A (ru) 2011-11-27
KR20100087170A (ko) 2010-08-03
MX2010004291A (es) 2010-08-02
AU2008313622A1 (en) 2009-04-23
JP2011500649A (ja) 2011-01-06
ECSP10010183A (es) 2010-06-29
WO2009050291A3 (fr) 2010-04-08

Similar Documents

Publication Publication Date Title
ZA201002130B (en) Solid dispersion product containing n-aryl urea-based compound
EP2251038A4 (fr) Dispersion solide, compositions pharmaceutiques comprenant celle-ci, et procédés de production associés
IL242883B (en) Aryl-amino and heteroaryl-amino converted deoxazolines and pharmaceutical preparations containing them
IL200654A (en) Benzyl and peridinyl derivatives as regulators of the Hedgehog signal transmission pathway and pharmaceutical preparations containing them
EP2150109A4 (fr) Utilisation pharmaceutique d'amides substitués
IL199853A (en) Converged history of 5-Hydroxy-Admentil-2-Reindeer and Pharmaceutical Preparation containing them
HK1160762A1 (zh) 料盒、用於固體藥物部分的藥物分配器以及它們的使用
IL202892A (en) Diphthoid drugs, the process of making and using them to make the resulting drugs and drugs
EP2187968A4 (fr) Mélange thermocinétique pour des applications pharmaceutiques
EP2265731A4 (fr) Procédés et composition pour évaluer la réponse aux médicaments
ZA201002095B (en) Solid dispersion product of n-aryl urea-based drugs
EP2166874A4 (fr) Compositions pour microencapsulation, leurs procédés de fabrication et d'utilisation et produits obtenus à partir de celles-ci
HRP20181854T1 (hr) Farmaceutski pripravak sporog oslobađanja pripremljen od mikročestica
AP2920A (en) Anti-malarial pharmaceutical composition
IL200810A0 (en) Pharmaceutical formulations of ghrh molecules
GB0813340D0 (en) Facilitating dynamic configuration of software products
IL208788A (en) Pharmacy-based formulation
PT2484661T (pt) Derivado de 2,3-di-hidro-1h-inden-2-il-ureia e sua aplicação farmacêutica
EP2195332A4 (fr) Modulateurs des réactions d'hypersensibilité
EP2471782A4 (fr) Nouveau dérivé de sulfonamide et composition pharmaceutique le contenant
HK1131039A1 (en) Pharmaceutical use of sophoricoside
PL2410997T3 (pl) Kompozycja do podawania polimerycznych leków